Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 7, 2016, Pages 662-672

  Polyviou, T ^a   MacDougall, K ^b   Chambers, E S ^c   Viardot, A ^c   Psichas, A ^c   Jawaid, S ^b   Harris, H C ^d   Edwards, C A ^d   Simpson, L ^a,b   Murphy, K G ^c   Zac Varghese, S E K ^c   Blundell, J E ^e   Dhillo, W S ^c   Bloom, S R ^c   Frost, G S ^c   Preston, T ^a   Tedford, M C ^b   Morrison, D J ^a  

^a SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; ENEMA; INULIN; INULIN PROPIONATE ESTER 27; INULIN PROPIONATE ESTER 54; PROPIONIC ACID; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; ESTER; PROPIONIC ACID DERIVATIVE; VOLATILE FATTY ACID;

AREA UNDER THE CURVE; ARTICLE; BATCH FERMENTATION; BLOOD SAMPLING; BODY MASS; CALORIC INTAKE; COLON; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG DELIVERY SYSTEM; ESTERIFICATION; FATTY ACID TRANSPORT; FOOD INTAKE; GLUCOSE REGULATION SYSTEM; HUMAN; IMMUNE FUNCTION TEST; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTESTINE FLORA; LIFESTYLE; NONHUMAN; OBESITY; ORGANOLEPTIC PROPERTY; PALATABILITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS FLUORESCENS; RANDOMIZED CONTROLLED TRIAL; RHIZOMUCOR MIEHEI; SINGLE DRUG DOSE; SYNTHESIS; VISUAL ANALOG SCALE; YARROWIA LIPOLYTICA; ADULT; CHEMISTRY; EATING; FECES; FERMENTATION; MALE; METABOLISM; MIDDLE AGED;

ADULT; COLON; CROSS-OVER STUDIES; EATING; ENERGY INTAKE; ESTERS; FATTY ACIDS, VOLATILE; FECES; FERMENTATION; HUMANS; INULIN; MALE; MIDDLE AGED; PROPIONATES;

EID: 84991387364     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13749     Document Type: Article

References (51)

1. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451–5.
2. De Vadder F, Kovatcheva-Datchary P, Goncalves D, et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014; 156: 84–96.
3. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569–73.
4. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159–66.
5. Zeng H, Lazarova DL, Bordonaro M. Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World J Gastrointest Oncol 2014; 6: 41–51.
6. Brown AJ, Goldsworthy SM, Barnes AA, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278: 11312–9.
7. Le Poul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278: 25481–9.
8. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 2003; 303: 1047–52.
9. So PW, Yu WS, Kuo YT, et al. Impact of resistant starch on body fat patterning and central appetite regulation. PLoS ONE 2007; 2: e1309.
10. Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009; 89: 1751–9.
11. Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006; 55: 1484–90.
12. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005; 82: 559–67.
13. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 2004; 92: 521–6.
14. Daud NM, Ismail NA, Thomas EL, et al. The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity (Silver Spring) 2014; 22: 1430–8.
15. Cherbut C, Ferrier L, Roze C, et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol 1998; 275(6 Pt 1): G1415–22.
16. Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61: 364–71.
17. Freeland KR, Wolever TM. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br J Nutr 2010; 103: 460–6.
18. National Diet and Nutrition Survey: results from Years 1 to 4 (combined) of the rolling programme for 2008 and 2009 to 2011 and 2012 - Publications - GOV.UK, 2015.
19. Hoy MK, G J. Fiber intake of the U.S. population: What We Eat in America, NHANES 2009-2010. In. Food Surveys Research Group Dietary Data Brief No. 12. September 2014.
20. Berggren AM, Nyman EM, Lundquist I, Bjorck IM. Influence of orally and rectally administered propionate on cholesterol and glucose metabolism in obese rats. Br J Nutr 1996; 76: 287–94.
21. Frost GS, Brynes AE, Dhillo WS, Bloom SR, McBurney MI. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur J Clin Nutr 2003; 57: 293–8.
22. Chambers E, Viardot A, Psichas A, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 2015; 64: 1744–54.
23. Tuleu C, Basit AW, Waddington WA, Ell PJ, Newton JM. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules. Aliment Pharmacol Ther 2002; 16: 1771–9.
24. Maurer JM, Schellekens RC, van Rieke HM, et al. Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets. PLoS ONE 2015; 10: e0129076.
25. Wolever TM, Brighenti F, Royall D, Jenkins AL, Jenkins DJ. Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol 1989; 84: 1027–33.
26. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221–7.
27. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81: 1031–64.
28. Pu H, Chen L, Li X, Xie F, Yu L, Li L. An oral colon-targeting controlled release system based on resistant starch acetate: synthetization, characterization, and preparation of film-coating pellets. J Agric Food Chem 2011; 59: 5738–45.
29. Clarke JM, Topping DL, Christophersen CT, et al. Butyrate esterified to starch is released in the human gastrointestinal tract. Am J Clin Nutr 2011; 94: 1276–83.
30. Andersson HB, Ellegard LH, Bosaeus IG. Nondigestibility characteristics of inulin and oligofructose in humans. J Nutr 1999; 129(7 Suppl.): 1428s–30s.
31. Nilsson U, Bjorck I. Availability of cereal fructans and inulin in the rat intestinal tract. J Nutr 1988; 118: 1482–6.
32. Giusti DM, Conway RA, CT L. Activated carbon adsorption of petrochemicals. J Water Pollut Control Fed 1974; 46: 249–53.
33. Parrett AM, Edwards CA. In vitro fermentation of carbohydrate by breast fed and formula fed infants. Arch Dis Child 1997; 76: 249–53.
34. Amarri S, Coward WA, Harding M, Weaver LT. Importance of measuring CO2-production rate when using 13C-breath tests to measure fat digestion. Br J Nutr 1998; 79: 541–5.
35. Cummings JH, Bingham SA, Heaton KW, Eastwood MA. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology 1992; 103: 1783–9.
36. Englyst HN, Kingman SM, Cummings JH. Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr 1992; 46(Suppl. 2): S33–50.
37. Anderson JW, Bridges SR. Short-chain fatty acid fermentation products of plant fiber affect glucose metabolism of isolated rat hepatocytes. Proc Soc Exp Biol Med 1984; 177: 372–6.
38. Lin Y, Vonk RJ, Slooff MJ, Kuipers F, Smit MJ. Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture. Br J Nutr 1995; 74: 197–207.
39. Wright RS, Anderson JW, Bridges SR. Propionate inhibits hepatocyte lipid synthesis. Proc Soc Exp Biol Med 1990; 195: 26–9.
40. Bach Knudsen KE, Hessov I. Recovery of inulin from Jerusalem artichoke (Helianthus tuberosus L.) in the small intestine of man. Br J Nutr 1995; 74: 101–13.
41. Molis C, Flourie B, Ouarne F, et al. Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr 1996; 64: 324–8.
42. Byrne C, Chambers E, Morrison DJ, Frost G. The Role of Short Chain Fatty Acids in Appetite Regulation and Energy Homeostasis. Int J Obes 2015; 39: 1331–38.
43. Chambers ES, Morrison DJ, Frost G. Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms? Proc Nutr Soc 2015; 74: 328–36.
44. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016; 7: 189–200.
45. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 2015; 11: 577–91.
46. Nilsson A, Granfeldt Y, Ostman E, Preston T, Bjorck I. Effects of GI and content of indigestible carbohydrates of cereal-based evening meals on glucose tolerance at a subsequent standardised breakfast. Eur J Clin Nutr 2006; 60: 1092–9.
47. Nilsson A, Ostman E, Preston T, Bjorck I. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 2008; 62: 712–20.
48. Nilsson AC, Ostman EM, Holst JJ, Bjorck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 2008; 138: 732–9.
49. Mossi S, Meyer-Wyss B, Beglinger C, et al. Gastric emptying of liquid meals measured noninvasively in humans with [13C]acetate breath test. Dig Dis Sci 1994; 39(12 Suppl.): 107s–9s.
50. Jouet P, Moussata D, Duboc H, et al. Effect of short-chain fatty acids and acidification on the phasic and tonic motor activity of the human colon. Neurogastroenterol Motil 2013; 25: 943–9.
51. Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011; 12: 62–76.